Get started
Author

Romana Zaoralová

Observed names: R Zaoralova, R. Zaoralova, Romana Zaoralova
Institution: Masaryk University
ORCID: 0000-0001-7449-7679
Observed ORCID: 0000-0001-7449-7679
OpenAlex ID: A5021172728
Genome-Wide Screening of Cytogenetic Abnormalities in Multiple Myeloma Patients Using Array-CGH Technique: A Czech Multicenter Experience
2014 · Jan Smetana, Jan Frohlich, et al. · BioMed Research International · 27
PDF
Gain(1)(q21) is an Unfavorable Genetic Prognostic Factor for Patients With Relapsed Multiple Myeloma Treated With Thalidomide but Not for Those Treated With Bortezomib
2013 · Jan Smetana, Kristina Berankova, et al. · Clinical Lymphoma Myeloma & Leukemia · 23
Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation
2010 · H. Greslikova, R. Zaoralova, et al. · Neoplasma · 19
PDF
Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma
2010 · E. Dementyeva, P. Nemec, et al. · Leukemia Research · 11
Incidence of Centrosome Amplification in Multiple Myeloma.
2009 · Jana Smejkalova, Elena Dementyeva, et al. · Blood · 1
P140 Prognostic impact of 1q21 amplification in patients with multiple myeloma treated by velcade, thalidomide and any conventional chemotherapy
2007 · P. Nemec, P. Kuglik, et al. · Blood Reviews · 1
Comparison of prognostic impact of chromosome 1q21 gain inpatients with multiple myeloma treated by Velcade, thalidomideand any conventional therapy
2007 · Pavel Němec, Henrieta Grešlíková, et al. · 1
P-17 High resolution oligonucleotide array-CGH method for preimplantation genetic screening: preclinical validation and first clinical results
2013 · V. Vallova, D. Paralova, et al. · Reproductive BioMedicine Online
PDF
Chromosomal abnormalities in monoclonal gammopathy ofundetermined significance patients analyzed by fluorescence insitu hybridization and oligonucleotide based array comparativegenomic hybridization
2011 · Aneta Mikulášová, Jan Smetana, et al.
Vyšetření specifických chromozomových abnormalit u monoklonálnígamapatie nejasného významu pomocí interfázní fluorescenční insitu hybridizace
2011 · Aneta Mikulášová, Petr Kuglík, et al.
Nestin - prognostický a myelom-specifický marker pro mnohočetný myelom?
2011 · Hana Šváchová, Luděk Pour, et al.
Array-CGH in multiple myeloam research
2011 · Jan Smetana, Aneta Mikulášová, et al.
First experience with whole genome amplification for aCGHinvestigation of chromosomal abnormalities in MGUS patients
2011 · Aneta Mikulášová, Jan Smetana, et al.
Detection of new protein alterations in human B-lymphoblastoidcell line ARH-77 after bortezomib treatment
2011 · Anna Potáčová, Jana Štossová, et al.
Celogenomová analýza pacientov s mnohopočetným myelomom pomocouoligonukleotidových DNA čipov a motódy array-CGH.
2011 · Henrieta Grešlíková, Renata Kupská, et al.
Association Study of Ploidy Category with Mitotic Disruption In Multiple Myeloma
2010 · Elena Dementyeva, Fedor Kryukov, et al. · Blood
Vliv fluorescenčně aktivované separace na expresní profil buněkmyelomové linie
2010 · Romana Zaoralová, Henrieta Grešlíková, et al.
Prognostic and predictive impact of cytogenetic changes inrelapsed multiple myeloma patients treated with bortezomib orthalidomid based regiments: a Czech group experience
2010 · Jan Smetana, Petr Kuglík, et al.
FACS metóda - doležitý krok k úspěšnému molekulárne-cytogenetickému vyšetreniu u pacientov s monoklonálnou gamapatiou nejasného významu
2010 · Henrieta Grešlíková, Renata Kupská, et al.
Monoclonal gammopathy of undetermined significance -possibilities of molecular cytogenetic analysis in patientswith low percent of bone marow plasma cells infiltration
2010 · Aneta Mikulášová, Petr Kuglík, et al.
Oligonucleotide array-based comparative genomic hybridizationanalyses of gain 1q21 in multiple myeloma
2010 · Romana Zaoralová, Pavel Němec, et al.
Array CGH in multiple myeloma: Practical notes and ourpreliminary results
2010 · Romana Zaoralová, Pavel Němec, et al.
Gain(1)(q21) Defines Group of Newly Diagnosed Multiple Myeloma Patients with Poor Prognosis.
2009 · Pavel Nemec, Henrieta Greslikova, et al. · Blood
Genomová profilace mnohočetného myelomu pomocíoligonukleotidové array-CGH
2009 · Romana Zaoralová, Vladimíra Vranová, et al.
Molecular diagnostics of multiple myeloma using oligonucleotide array-based comparative genomic hybridization (array-CGH)
2009 · Romana Zaoralová, Vladimíra Vallová, et al.
Works count: 53
Citation count: 83
H-index: 4
I10-index: 4
Year
Topic
Type